QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
NYSE:ABT

Abbott Laboratories (ABT) Price Target & Analyst Ratings

$108.47
-0.35 (-0.32%)
(As of 05/18/2023 ET)
Compare
Today's Range
$107.87
$108.84
50-Day Range
$96.86
$112.29
52-Week Range
$93.25
$118.23
Volume
3.48 million shs
Average Volume
5.10 million shs
Market Capitalization
$188.62 billion
P/E Ratio
32.97
Dividend Yield
1.88%
Price Target
$122.37

Abbott Laboratories Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 16 Analyst Ratings

Consensus Analyst Price Target

$122.37
12.81% Upside
High Prediction$136.00
Average Prediction$122.37
Low Prediction$102.00
TypeCurrent
5/18/22 to 5/18/23
1 Month Ago
4/18/22 to 4/18/23
3 Months Ago
2/17/22 to 2/17/23
1 Year Ago
5/18/21 to 5/18/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
11 Buy rating(s)
10 Buy rating(s)
11 Buy rating(s)
12 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$122.37$121.88$125.63$139.59
Predicted Upside12.81% Upside15.95% Upside16.66% Upside16.00% Upside
Get Abbott Laboratories Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter.


ABT Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ABT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Abbott Laboratories Stock vs. The Competition

TypeAbbott LaboratoriesMedical CompaniesS&P 500
Consensus Rating Score
2.63
2.66
2.48
Consensus RatingModerate BuyBuyHold
Predicted Upside13.03% Upside1,400.60% Upside169.44% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/20/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$116.00 ➝ $123.00+11.31%
4/20/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderperform$107.00 ➝ $103.00-7.50%
4/20/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$132.00 ➝ $133.00+19.44%
4/20/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$118.00 ➝ $122.00+9.56%
4/20/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$117.00 ➝ $130.00+15.77%
4/20/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$125.00 ➝ $127.00+13.10%
4/19/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$125.00 ➝ $130.00+15.77%
4/17/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$125.00 ➝ $130.00+25.05%
4/5/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$140.00 ➝ $136.00+32.30%
3/31/2023SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$90.00 ➝ $102.00+2.95%
3/30/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$125.00 ➝ $115.00+16.61%
1/26/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$110.00 ➝ $125.00+12.35%
1/24/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$105.00 ➝ $110.00-3.52%
1/6/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$117.00 ➝ $133.00+20.04%
10/20/2022Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$110.00+15.53%
10/20/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$132.00 ➝ $126.00+28.43%
10/12/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$110.00+8.11%
8/25/2022Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Hans Engel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
7/13/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$150.00 ➝ $130.00+22.02%
(Data available from 5/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












ABT Price Target - Frequently Asked Questions

What is Abbott Laboratories's consensus rating and price target?

According to the issued ratings of 16 analysts in the last year, the consensus rating for Abbott Laboratories stock is Moderate Buy based on the current 1 sell rating, 4 hold ratings and 11 buy ratings for ABT. The average twelve-month price prediction for Abbott Laboratories is $122.37 with a high price target of $136.00 and a low price target of $102.00. Learn more on ABT's analyst rating history.

Do Wall Street analysts like Abbott Laboratories more than its competitors?

Analysts like Abbott Laboratories less than other Medical companies. The consensus rating for Abbott Laboratories is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how ABT compares to other companies.

Does Abbott Laboratories's stock price have much upside?

According to analysts, Abbott Laboratories's stock has a predicted upside of 14.03% based on their 12-month price targets.

What analysts cover Abbott Laboratories?

Stock Ratings Reports and Tools

This page (NYSE:ABT) was last updated on 5/18/2023 by MarketBeat.com Staff

My Account -